Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
J Clin Microbiol ; 60(9): e0021722, 2022 09 21.
Article in English | MEDLINE | ID: mdl-35969171

ABSTRACT

The Bruker Biotyper matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) platform was assessed on its ability to accurately identify 314 nontuberculous mycobacteria (NTM) representing 73 species. All NTM isolates, representing 183 rapidly growing and 131 slowly growing organisms, were previously identified by Sanger DNA sequencing of the full-length 16S rRNA gene, and region V of the rpoB gene. An optimized version of the Bruker bead-beating procedure for protein extraction of NTM isolates was used to ensure high quality spectra for all NTM isolates, including less frequently encountered species. NTM spectra were analyzed using Bruker's research use only, Mycobacteria Library v6.0, supplemented by the MicrobeNet database. Identification of NTM by MALDI-TOF had an accuracy of 94% (296/314). The identification accuracy for rapidly growing mycobacteria was higher at 99% (182/183) than it was for slowly growing mycobacteria at 87% (114/131). While MALDI-TOF performed well against Sanger sequencing of the 16S rRNA gene alone, there were 11 species that required additional sequencing of rpoB. Most discrepancies between MALDI-TOF and sequencing results are likely due to underrepresentation of some species in the libraries used. Overall, the results of this study support Bruker's MALDI-TOF platform as an accurate and reliable method for the identification of NTM.


Subject(s)
Mycobacterium Infections, Nontuberculous , Nontuberculous Mycobacteria , Humans , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
2.
Infect Control Hosp Epidemiol ; 38(3): 314-319, 2017 03.
Article in English | MEDLINE | ID: mdl-27919308

ABSTRACT

OBJECTIVE To determine the source of a healthcare-associated outbreak of Pantoea agglomerans bloodstream infections. DESIGN Epidemiologic investigation of the outbreak. SETTING Oncology clinic (clinic A). METHODS Cases were defined as Pantoea isolation from blood or catheter tip cultures of clinic A patients during July 2012-May 2013. Clinic A medical charts and laboratory records were reviewed; infection prevention practices and the facility's water system were evaluated. Environmental samples were collected for culture. Clinical and environmental P. agglomerans isolates were compared using pulsed-field gel electrophoresis. RESULTS Twelve cases were identified; median (range) age was 65 (41-78) years. All patients had malignant tumors and had received infusions at clinic A. Deficiencies in parenteral medication preparation and handling were identified (eg, placing infusates near sinks with potential for splash-back contamination). Facility inspection revealed substantial dead-end water piping and inadequate chlorine residual in tap water from multiple sinks, including the pharmacy clean room sink. P. agglomerans was isolated from composite surface swabs of 7 sinks and an ice machine; the pharmacy clean room sink isolate was indistinguishable by pulsed-field gel electrophoresis from 7 of 9 available patient isolates. CONCLUSIONS Exposure of locally prepared infusates to a contaminated pharmacy sink caused the outbreak. Improvements in parenteral medication preparation, including moving chemotherapy preparation offsite, along with terminal sink cleaning and water system remediation ended the outbreak. Greater awareness of recommended medication preparation and handling practices as well as further efforts to better define the contribution of contaminated sinks and plumbing deficiencies to healthcare-associated infections are needed. Infect Control Hosp Epidemiol 2017;38:314-319.


Subject(s)
Bacteremia/diagnosis , Cross Infection/diagnosis , Disease Outbreaks , Drug Contamination , Pantoea/isolation & purification , Adult , Aged , Electrophoresis, Gel, Pulsed-Field , Equipment Contamination , Female , Humans , Illinois , Male , Middle Aged , Oncology Service, Hospital
3.
Emerg Infect Dis ; 22(8): 1340-1347, 2016 08.
Article in English | MEDLINE | ID: mdl-27434822

ABSTRACT

During 2013, the Maryland Department of Health and Mental Hygiene in Baltimore, MD, USA, received report of 2 Maryland residents whose surgical sites were infected with rapidly growing mycobacteria after cosmetic procedures at a clinic (clinic A) in the Dominican Republic. A multistate investigation was initiated; a probable case was defined as a surgical site infection unresponsive to therapy in a patient who had undergone cosmetic surgery in the Dominican Republic. We identified 21 case-patients in 6 states who had surgery in 1 of 5 Dominican Republic clinics; 13 (62%) had surgery at clinic A. Isolates from 12 (92%) of those patients were culture-positive for Mycobacterium abscessus complex. Of 9 clinic A case-patients with available data, all required therapeutic surgical intervention, 8 (92%) were hospitalized, and 7 (78%) required ≥3 months of antibacterial drug therapy. Healthcare providers should consider infection with rapidly growing mycobacteria in patients who have surgical site infections unresponsive to standard treatment.


Subject(s)
Medical Tourism , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium abscessus , Adolescent , Adult , Disease Outbreaks , Dominican Republic/epidemiology , Female , Humans , Middle Aged , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/economics , Surgery, Plastic/adverse effects , Surgical Wound Infection , United States/epidemiology , Young Adult
4.
Genome Announc ; 4(2)2016 Mar 17.
Article in English | MEDLINE | ID: mdl-26988052

ABSTRACT

Mycobacterium wolinskyi is a nonpigmented, rapidly growing nontuberculous mycobacterium species that is associated with bacteremia, peritonitis, infections associated with implants/prostheses, and skin and soft tissue infections often following surgical procedures in humans. Here, we report the first functionally annotated draft genome sequence of M. wolinskyi CDC_01.

5.
Am J Infect Control ; 42(7): 731-4, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24969124

ABSTRACT

BACKGROUND: Four patients were hospitalized July 2011 with Pseudomonas aeruginosa bloodstream infection (BSI), 2 of whom also had Klebsiella pneumoniae BSI. All 4 patients had an indwelling port and received infusion services at the same outpatient oncology center. METHODS: Cases were defined by blood or port cultures positive for K pneumoniae or P aeruginosa among patients receiving infusion services at the oncology clinic during July 5-20, 2011. Pulsed-field gel electrophoresis (PFGE) was performed on available isolates. Interviews with staff and onsite investigations identified lapses of infection control practices. Owing to concerns over long-standing deficits, living patients who had been seen at the clinic between January 2008 and July 2011 were notified for viral blood-borne pathogen (BBP) testing; genetic relatedness was determined by molecular testing. RESULTS: Fourteen cases (17%) were identified among 84 active clinic patients, 12 of which involved symptoms of a BSI. One other patient had a respiratory culture positive for P aeruginosa but died before blood cultures were obtained. Available isolates were indistinguishable by PFGE. Multiple injection safety lapses were identified, including overt syringe reuse among patients and reuse of syringes to access shared medications. Available BBP results did not demonstrate iatrogenic viral infection in 331 of 623 notified patients (53%). CONCLUSIONS: Improper preparation and handling of injectable medications likely caused the outbreak. Increased infection control oversight of oncology clinics is critical to prevent similar outbreaks.


Subject(s)
Ambulatory Care Facilities , Bacteremia/epidemiology , Disease Outbreaks , Klebsiella Infections/epidemiology , Pseudomonas Infections/epidemiology , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Bacteremia/microbiology , Drug Therapy/methods , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Humans , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/isolation & purification , Male , Middle Aged , Molecular Typing , Neoplasms/complications , Neoplasms/drug therapy , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification
7.
Clin Infect Dis ; 59(1): 1-8, 2014 Jul 01.
Article in English | MEDLINE | ID: mdl-24729502

ABSTRACT

BACKGROUND: Compounding pharmacies often prepare parenteral nutrition (PN) and must adhere to rigorous standards to avoid contamination of the sterile preparation. In March 2011, Serratia marcescens bloodstream infections (BSIs) were identified in 5 patients receiving PN from a single compounding pharmacy. An investigation was conducted to identify potential sources of contamination and prevent further infections. METHODS: Cases were defined as S. marcescens BSIs in patients receiving PN from the pharmacy between January and March 2011. We reviewed case patients' clinical records, evaluated pharmacy compounding practices, and obtained epidemiologically directed environmental cultures. Molecular relatedness of available Serratia isolates was determined by pulsed-field gel electrophoresis (PFGE). RESULTS: Nineteen case patients were identified; 9 died. The attack rate for patients receiving PN in March was 35%. No case patients were younger than 18 years. In October 2010, the pharmacy began compounding and filter-sterilizing amino acid solution for adult PN using nonsterile amino acids due to a national manufacturer shortage. Review of this process identified breaches in mixing, filtration, and sterility testing practices. S. marcescens was identified from a pharmacy water faucet, mixing container, and opened amino acid powder. These isolates were indistinguishable from the outbreak strain by PFGE. CONCLUSIONS: Compounding of nonsterile amino acid components of PN was initiated due to a manufacturer shortage. Failure to follow recommended compounding standards contributed to an outbreak of S. marcescens BSIs. Improved adherence to sterile compounding standards, critical examination of standards for sterile compounding from nonsterile ingredients, and more rigorous oversight of compounding pharmacies is needed to prevent future outbreaks.


Subject(s)
Bacteremia/epidemiology , Disease Outbreaks , Parenteral Nutrition/adverse effects , Pharmacy , Serratia Infections/epidemiology , Serratia marcescens/isolation & purification , Adult , Aged , Aged, 80 and over , Drug Compounding/standards , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Humans , Male , Middle Aged , Molecular Typing , Serratia marcescens/classification , Serratia marcescens/genetics
8.
MMWR Morb Mortal Wkly Rep ; 63(9): 201-2, 2014 Mar 07.
Article in English | MEDLINE | ID: mdl-24598597

ABSTRACT

In August 2013, the Maryland Department of Health and Mental Hygiene (MDHMH) was notified of two persons with rapidly growing nontuberculous mycobacterial (RG-NTM) surgical-site infections. Both patients had undergone surgical procedures as medical tourists at the same private surgical clinic (clinic A) in the Dominican Republic the previous month. Within 7 days of returning to the United States, both sought care for symptoms that included surgical wound abscesses, clear fluid drainage, pain, and fever. Initial antibiotic therapy was ineffective. Material collected from both patients' wounds grew Mycobacterium abscessus exhibiting a high degree of antibiotic resistance characteristic of this organism.


Subject(s)
Disease Outbreaks , Medical Tourism , Mycobacterium Infections/epidemiology , Mycobacterium/classification , Plastic Surgery Procedures/adverse effects , Surgical Wound Infection/epidemiology , Adolescent , Adult , Centers for Disease Control and Prevention, U.S. , Dominican Republic , Female , Humans , Middle Aged , Mycobacterium/isolation & purification , Mycobacterium Infections/etiology , Surgical Wound Infection/etiology , United States/epidemiology , Young Adult
9.
Infect Control Hosp Epidemiol ; 35(4): 406-11, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24602946

ABSTRACT

OBJECTIVE: To investigate Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility (LTCF) providing subacute care (facility A). METHODS: We reviewed facility A and affiliated local hospital records for facility A residents with A. baumannii isolated during the period January 2009 through February 2010 and compared A. baumannii antimicrobial resistance patterns of residents with those of hospital patients. During March 2010, we implemented a colonization survey of facility A residents who received respiratory support or who could provide sputum samples and looked for A. baumannii colonization risks. Available clinical and survey isolates underwent pulsed-field gel electrophoresis (PFGE); PFGE strains were linked with overlapping stays to identify possible transmission. RESULTS: During the period January 2009 through February 2010, 33 facility A residents had A. baumannii isolates; all strains were multidrug resistant (MDR), which was a significantly higher prevalence of MDR strains than that found among isolates from hospital patients (81 [66%] of 122 hospital patient isolates were MDR; P < .001). The sputum survey found that 14 (20%) of 70 residents had A. baumannii colonization, which was associated with ventilator use (adjusted odds ratio, 4.24 [95% confidence interval, 1.06-16.93]); 12 (86%) of 14 isolates were MDR. Four facility A resident groups clustered with 3 PFGE strains and overlapping stays. One of these facility A residents also clustered with 3 patients at an affiliated hospital. CONCLUSIONS: We documented substantial MDR A. baumannii infections and colonization with probable intra- and interfacility spread associated with a single LTCF providing subacute care. Given the limited infection prevention and antimicrobial stewardship resources in such settings, regional collaborations among facilities across the spectrum of health care are needed to address this MDR threat.


Subject(s)
Acinetobacter Infections/transmission , Acinetobacter baumannii/isolation & purification , Cross Infection , Drug Resistance, Multiple, Bacterial , Skilled Nursing Facilities/organization & administration , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/growth & development , Adult , Aged , Aged, 80 and over , California , Female , Humans , Male , Medical Audit , Middle Aged , Odds Ratio
10.
Aesthet Surg J ; 33(2): 265-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23335647

ABSTRACT

UNLABELLED: A cluster of 3 facial Mycobacterium chelonae infections occurred after cosmetic dermal filler injections at a plastic surgery clinic. Pulsed-field gel electrophoresis showed that M chelonae isolated from the clinic tap water were identical to the patient wound isolates. Review of injection procedures identified application of nonsterile ice to the skin prior to injection as a possible source of M chelonae. Surveys of regional laboratories and a national plastic surgery listserv identified no other cases related to the injection of this brand of dermal filler. This is the first report of cutaneous M chelonae infections following the injection of dermal fillers. It adds to a growing body of literature on postinjection M chelonae infections and reinforces the importance of optimal skin disinfection steps prior to percutaneous procedures. LEVEL OF EVIDENCE: 5.


Subject(s)
Cosmetic Techniques/adverse effects , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium chelonae/isolation & purification , Cosmetic Techniques/standards , Electrophoresis, Gel, Pulsed-Field , Face , Female , Humans , Ice/standards , Middle Aged , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Water Microbiology , Water Supply
11.
Foodborne Pathog Dis ; 9(9): 861-7, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22891917

ABSTRACT

Cronobacter (formerly known as Enterobacter sakazakii) is a genus comprising seven species regarded as opportunistic pathogens that can be found in a wide variety of environments and foods, including powdered infant formula (PIF). Cronobacter sakazakii, the major species of this genus, has been epidemiologically linked to cases of bacteremia, meningitis in neonates, and necrotizing enterocolitis, and contaminated PIF has been identified as an important source of infection. Robust and reproducible subtyping methods are required to aid in the detection and investigation, of foodborne outbreaks. In this study, a pulsed-field gel electrophoresis (PFGE) protocol was developed and validated for subtyping Cronobacter species. It was derived from an existing modified PulseNet protocol, wherein XbaI and SpeI were the primary and secondary restriction enzymes used, generating an average of 14.7 and 20.3 bands, respectively. The PFGE method developed was both reproducible and discriminatory for subtyping Cronobacter species.


Subject(s)
Cronobacter/classification , Molecular Typing/methods , Amplified Fragment Length Polymorphism Analysis , Animals , Cronobacter/genetics , Cronobacter/isolation & purification , Cronobacter/metabolism , Cronobacter sakazakii/classification , Cronobacter sakazakii/genetics , Cronobacter sakazakii/isolation & purification , Cronobacter sakazakii/metabolism , DNA Restriction Enzymes , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Bacterial/metabolism , Electrophoresis, Gel, Pulsed-Field , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Food, Preserved/microbiology , Foodborne Diseases/diagnosis , Foodborne Diseases/microbiology , Humans , Milk/microbiology , Reproducibility of Results , Vibrio cholerae/classification , Vibrio cholerae/genetics , Vibrio cholerae/isolation & purification , Vibrio cholerae/metabolism , Yersinia pestis/classification , Yersinia pestis/genetics , Yersinia pestis/isolation & purification , Yersinia pestis/metabolism
12.
Am J Infect Control ; 40(2): 144-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21764479

ABSTRACT

BACKGROUND: Recent outbreaks in ambulatory care settings have highlighted infection control breaches as risk factors for disease transmission. In May 2009, 3 patients were hospitalized with severe methicillin-susceptible Staphylococcus aureus (MSSA) infections after receiving epidural injections at a West Virginia outpatient pain clinic. METHODS: We conducted a retrospective cohort study evaluating clinic patients who received injections during a 3-week period. A case was defined as laboratory-confirmed infection or clinical evidence of infection ≤ 14 days after a patient received an injection. Infection control procedures were assessed. MSSA isolates from patient infections and clinic staff nasal swabs were genotyped by using pulsed-field gel electrophoresis. RESULTS: Eight (7%) of 110 cohort patients met the case definition; 6 (75%) cases were laboratory confirmed. Eight (12%) of 69 patients who received epidural injections were case patients compared with none of the other 41 patients (P = .02). During procedures, staff use of face masks and preparation of patient skin were suboptimal; epidural injection syringes were reused to access shared medication vials. MSSA isolates from 2 patients and 1 staff member were indistinguishable by pulsed-field gel electrophoresis. CONCLUSION: Infection control breaches likely facilitated MSSA transmission to patients receiving epidural injections. Adhering to correct infection control practices in ambulatory care settings is critical to prevent disease transmission.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cross Infection/transmission , Disease Outbreaks , Infection Control/standards , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/transmission , Syringes/microbiology , Adult , Aged , Aged, 80 and over , Analgesics/administration & dosage , Anti-Bacterial Agents/administration & dosage , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Female , Guideline Adherence , Humans , Injections, Epidural , Male , Middle Aged , Nasal Cavity/microbiology , Pain/drug therapy , Pain Clinics , Retrospective Studies , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology
14.
Infect Control Hosp Epidemiol ; 31(12): 1257-63, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21029006

ABSTRACT

BACKGROUND: In 2007-2008, several US hospitals reported summertime increases in the number of clinical blood cultures positive for Bacillus species, which are common environmental bacteria. OBJECTIVE: To investigate increased rates of isolation of Bacillus species from blood cultures, identify risk factors, and recommend control strategies. DESIGN: Survey and case-control study. SETTING: Multiple hospitals, including a cancer center. METHODS: We surveyed 24 facilities that reported increases. We also conducted a field investigation at a hospital with a high rate, reviewing charts, collecting clinical and environmental isolates, and observing infection control procedures. A case-control study compared inpatient case patients who had any blood culture positive for Bacillus with unmatched control patients who had a blood culture with no growth during June-August 2008. RESULTS: Among surveyed facilities, mean monthly rates rose from 25 to a peak of 75 Bacillus-positive blood cultures per 10,000 blood cultures performed during the period June-August. At the hospital where the case-control investigation was conducted, for most case patients (75%), the Bacillus-positive blood cultures represented contamination or device colonization rather than infection. We enrolled 48 case patients and 48 control patients; in multivariate analysis, only central venous access device use was significantly associated with case status (odds ratio, 14.0; [Formula: see text]). Laboratory testing identified at least 12 different Bacillus species (non-anthracis) among the isolates. Observation of infection control procedures revealed variability in central line care and blood sample collection techniques. CONCLUSIONS: Periodic increases in the environmental load of Bacillus species may occur in hospitals. Our investigation indicated that at one facility, these increases likely represented a pseudo-outbreak of Bacillus species colonizing central venous lines or their accessories, such as needleless connector devices. Vigilant attention should be paid to infection control practices when collecting blood samples for culture, to minimize the risk of contamination by environmental microorganisms.


Subject(s)
Bacillus/isolation & purification , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Child , Child, Preschool , Equipment Contamination/prevention & control , Female , Gram-Positive Bacterial Infections/prevention & control , Hospitals , Humans , Infection Control/methods , Male , Middle Aged , Multivariate Analysis , Risk Factors , United States/epidemiology , Young Adult
16.
Infect Control Hosp Epidemiol ; 31(5): 522-7, 2010 May.
Article in English | MEDLINE | ID: mdl-20350149

ABSTRACT

OBJECTIVE: To identify risk factors for polymicrobial bloodstream infections (BSIs) in pediatric bone marrow transplant (BMT) outpatients attending a newly constructed clinic affiliated with a children's hospital. METHODS: All 30 outpatients treated at a new BMT clinic during September 10-21, 2007, were enrolled in a cohort study. The investigation included interviews, medical records review, observations, and bacterial culture and molecular typing of patient and environmental isolates. Data were analyzed using exact conditional logistic regression. RESULTS: Thirteen patients experienced BSIs caused by 16 different, predominantly gram-negative organisms. Presence of a tunneled catheter (odds ratio [OR], 19.9 [95% confidence interval {CI}, 2.4-infinity), catheter access (OR, 13.7 [95% CI, 1.8-infinity]), and flushing of a catheter with predrawn saline (OR, 12.9 [95% CI, 1.0-766.0]) were independently associated with BSI. The odds of experiencing a BSI increased by a factor of 16.8 with each additional injection of predrawn saline (95% CI, 1.8-827.0). Although no environmental source of pathogens was identified, interviews revealed breaches in recommended infection prevention practice and medication handling. Saline flush solutions were predrawn, and multiple doses were obtained from single-dose preservative-free vials to avoid delays in patient care. CONCLUSION: We speculate that infection prevention challenges in the new clinic, combined with successive needle punctures of vials, facilitated extrinsic contamination and transmission of healthcare-associated pathogens. We recommend that preservative-free single-use vials not be punctured more than once. Use of single-use prefilled saline syringes might prevent multiuse of single-use saline vials. Storage of saline outside a medication supply system might be advisable. Before opening new clinic facilities, hospitals should consider conducting a mock patient flow exercise to identify infection control challenges.


Subject(s)
Bone Marrow Transplantation/adverse effects , Catheter-Related Infections/epidemiology , Cross Infection/epidemiology , Gram-Negative Bacterial Infections/epidemiology , Outpatients/statistics & numerical data , Adolescent , Catheter-Related Infections/microbiology , Catheter-Related Infections/prevention & control , Catheterization, Central Venous/adverse effects , Catheters, Indwelling/adverse effects , Catheters, Indwelling/microbiology , Child , Child, Preschool , Cohort Studies , Cross Infection/microbiology , Cross Infection/prevention & control , Female , Georgia , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/prevention & control , Hospitals, Pediatric/statistics & numerical data , Humans , Infant , Infection Control/methods , Male , Outpatient Clinics, Hospital , Risk Factors
17.
Vet Microbiol ; 141(1-2): 174-7, 2010 Feb 24.
Article in English | MEDLINE | ID: mdl-19709820

ABSTRACT

The aim of this study is to document the isolation of a hypermucoviscosity (HMV) phenotype of Klebsiella pneumoniae from 25 cases of suppurative pneumonia and pleuritis and two cases of abscesses in California sea lions (Zalophus californianus) from the central California coast, representing the first report of this zoonotic pathogen from the marine environment and only the second report in non-humans. Animals died 2h to 4 days after first being observed sick on beaches. Clinical signs varied from dyspnoea to coma. Gross post-mortem examination of 25 cases revealed fibrinous pleuritis, copious pus in the pleural cavity and suppurative bronchopneumonia. K. pneumoniae isolates obtained from lung and pleural swabs and the hepatic and subcuticular abscesses were highly mucoid on blood agar culture media and were positive to the "string test". Twenty-one of the 27 isolates were examined by PCR and all were positive for rmpA and K2wyz and negative for K1magA genes. Although pneumonia and pleuritis have previously commonly been observed in marine mammals, their association with pure cultures of a zoonotic bacteria, K. pneumoniae HMV phenotype, has not. This report provides further evidence of the role marine mammals play as sentinels of health risks to humans from coastal waters.


Subject(s)
Klebsiella Infections/veterinary , Klebsiella pneumoniae/physiology , Phenotype , Pleurisy/veterinary , Pneumonia/veterinary , Sea Lions/microbiology , Animals , Klebsiella Infections/microbiology , Klebsiella Infections/pathology , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/pathogenicity , Pleurisy/microbiology , Pleurisy/pathology , Pneumonia/microbiology , Pneumonia/pathology , Polymerase Chain Reaction
18.
Arch Intern Med ; 169(18): 1705-11, 2009 Oct 12.
Article in English | MEDLINE | ID: mdl-19822828

ABSTRACT

BACKGROUND: To investigate clusters of Serratia marcescens (SM) bloodstream infections (BSIs) at health care facilities in several states and determine whether contaminated prefilled heparin and isotonic sodium chloride solution (hereinafter, saline) syringes from a single manufacturer (company X) were the likely cause, we performed an outbreak investigation of inpatient and outpatient health care facilities from October 2007 through February 2008. METHODS: Active case finding for clusters of SM BSIs. Information on SM BSIs was obtained, and SM blood isolates were sent to the Centers for Disease Control and Prevention (CDC). Culture specimens were taken from various lots of prefilled heparin and saline syringes by health care facilities and the CDC to test for the presence of SM. The SM isolates from syringes and blood were compared by pulsed-field gel electrophoresis. RESULTS: A total of 162 SM BSIs in 9 states were reported among patients at facilities using prefilled heparin and/or saline syringes made by company X. Cultures of unopened prefilled heparin and saline syringes manufactured by company X grew SM. Of 83 SM blood isolates submitted to the CDC from 7 states, 70 (84%) were genetically related to the SM strain isolated from prefilled syringes. A US Food and Drug Administration inspection revealed that company X was not in compliance with quality system regulations. CONCLUSIONS: A multistate outbreak of SM BSIs was associated with intrinsic contamination of prefilled syringes. Our investigation highlights important issues in medication safety, including (1) the importance of pursuing possible product-associated outbreaks suggested by strong epidemiologic data even when initial cultures of the suspected product show no contamination and (2) the challenges of medical product recalls when production has been outsourced from one company to another.


Subject(s)
Disease Outbreaks/statistics & numerical data , Drug Contamination , Sepsis/epidemiology , Serratia Infections/epidemiology , Serratia marcescens , Adult , Aged , China , Drug Industry/standards , Drug and Narcotic Control , Electrophoresis, Gel, Pulsed-Field , Female , Heparin/administration & dosage , Humans , Isotonic Solutions/administration & dosage , Male , Middle Aged , Quality Control , Safety , Sepsis/microbiology , Serratia Infections/etiology , Sodium Chloride/administration & dosage , Syringes , United States/epidemiology , United States Food and Drug Administration
19.
Clin Infect Dis ; 48(11): 1580-3, 2009 Jun 01.
Article in English | MEDLINE | ID: mdl-19400746

ABSTRACT

We report 6 cases of postsurgical endophthalmitis due to gram-negative bacteria associated with contaminated trypan blue dye from a compounding pharmacy. Unopened trypan blue syringes yielded Pseudomonas aeruginosa and Burkholderia cepacia complex on culture, with pulsed-field gel electrophoresis patterns indistinguishable from patient isolates. Contamination of compounded medications should be considered when investigating outbreaks of postoperative endophthalmitis.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , Drug Contamination , Endophthalmitis/epidemiology , Gram-Negative Bacterial Infections/epidemiology , Ophthalmic Solutions , Surgical Wound Infection/epidemiology , Aged , Aged, 80 and over , Burkholderia cepacia complex/classification , Burkholderia cepacia complex/genetics , Burkholderia cepacia complex/isolation & purification , Cluster Analysis , Cross Infection/microbiology , DNA Fingerprinting , Electrophoresis, Gel, Pulsed-Field , Endophthalmitis/microbiology , Genotype , Gram-Negative Bacterial Infections/microbiology , Humans , Male , Middle Aged , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Surgical Wound Infection/microbiology , Trypan Blue
20.
Clin Infect Dis ; 47(11): 1372-9, 2008 Dec 01.
Article in English | MEDLINE | ID: mdl-18937575

ABSTRACT

BACKGROUND: Pharmaceutical compounding, the manipulation of ingredients to create a customized medication, is a widespread practice. In January 2005, the Centers for Disease Control and Prevention was notified of 4 cases of Pseudomonas fluorescens bacteremia that were traced to contaminated heparinized saline intravenous flush syringes prepared as a compounded medical product. PATIENTS AND METHODS: We reviewed medical records of symptomatic patients with P. fluorescens-positive cultures of blood specimens or sections of explanted catheters, reviewed the production process of syringes, performed syringe cultures, compared isolates by pulsed-field gel electrophoresis (PFGE), and examined catheters by scanning electron microscopy. RESULTS: We identified 80 patients in 6 states with P. fluorescens-positive cultures during December 2004-March 2006. Sixty-four patients (80%) had received a diagnosis of cancer. Seventy-four (99%) of 75 patients for whom information about catheter type was available had long-term indwelling catheters. Thirty-three (41%) of 80 cases were diagnosed 84-421 days after the patient's last potential exposure to a contaminated flush (delayed-onset cases). Compared with patients with early infection onset, more patients with delayed infection onset had venous ports (100% versus 50%; P <.001). By PFGE, clinical isolates from 50 (98%) of 51 patients were related to isolates cultured from unopened syringes. Scanning electron microscopy of explanted catheters revealed biofilms containing organisms morphologically consistent with P. fluorescens. CONCLUSION: This outbreak underscores important challenges in ensuring the safety of compounded pharmaceuticals and demonstrates the potential for substantially delayed infections after exposures to contaminated infusates. Exposures to compounded products should be considered when investigating outbreaks. Patients exposed to contaminated infusates require careful follow-up, because infections can occur long after exposure.


Subject(s)
Bacteremia/epidemiology , Catheters, Indwelling/adverse effects , Cross Infection/epidemiology , Disease Outbreaks , Pseudomonas Infections/epidemiology , Pseudomonas fluorescens/isolation & purification , Sodium Chloride/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Bacterial Typing Techniques , Blood/microbiology , Catheters, Indwelling/microbiology , Child , Child, Preschool , Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Infant , Infant, Newborn , Male , Microscopy, Electron, Scanning , Middle Aged , Pseudomonas Infections/microbiology , Pseudomonas fluorescens/classification , Pseudomonas fluorescens/genetics , Sodium Chloride/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...